Please assess the completion status of the following clinical trial:

Trial Title: Paricalcitol and Endothelial Function in Chronic Kidney Disease Patients (the PENNY Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with iPTH level \> 65 pg/ml; Ca between 8.4- 10.00 mg/dL and P between 2.9-4.5~* Negative serum pregnancy test for female subjects of childbering potential.~* Informed consent.~Exclusion Criteria:~* Use vitamin D supplements.~* Altered liver function tests (bilirubin, aminotransferases and total alkaline phosphatase \> 3 times the upper limit of normal ranges).~* Sympthomatic cardiovascular disease on the basis of clinical history. Cancer.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo capsules daily for 12 weeks.
- Paracalcitol (Type: EXPERIMENTAL): see Intervention description for details.

Based on this trial design, predict the completion outcome and termination type (if applicable).